Skip to main content
    G

    Gossamer Bio Inc (GOSS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $11.04
    +0.06 (+0.55%)

    Market Cap: $67.16M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Gossamer Bio Inc (GOSS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Gossamer Bio (GOSS) has a market cap of $67.16M and an enterprise value of $53.12M. It kept -159.49% of revenue as net income over the last 12 months. Revenue grew 78.03% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 20.90% below the market cap, as cash exceeds debt.

    Market Cap$67.16M
    Enterprise Value$53.12M
    Latest price (Nov 17, 2026)$11.04

    Key Dates

    The next earnings report is expected on Mar 15, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 15, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Fiscal Year EndDecember

    Valuation Ratios

    The price to sales ratio is 0.9x.

    P/S Ratio0.9x
    Forward P/S1.0x

    Price Statistics

    The stock is down 94.91% over 52 weeks and trades 5.85% above its 50-day average.

    Beta (1Y)2.55
    52-Week Change-94.91%
    1-Month Change+30.96%
    3-Month Change-11.88%
    6-Month Change-30.69%
    5-Year Change-98.96%
    Total Return (1Y)-94.91%
    Total Return (3Y CAGR)-44.85%
    Total Return (5Y CAGR)-58.66%
    Return vs SPY (1Y)-107.03%
    Max Drawdown (1Y)-97.22%
    Max Drawdown (3Y)-97.22%
    Sharpe Ratio (1Y)-1.56
    Correlation with SPY (1Y)0.18
    50-Day Average$10.43
    200-Day Average$29.44
    52-Week Range$8.29 to $309.60
    RSI (14 Days)55.3
    Average Volume (20 Days)175.65K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.60x current liabilities.

    Current Ratio0.60x
    Quick Ratio0.60x
    Interest Coverage4.82x

    Returns and Efficiency

    Return on invested capital is 147.40% over the last 12 months, against a 5-year average of -98.16%.

    Return on Assets (ROA)-194.40%
    Return on Invested Capital (ROIC)147.40%
    ROA (5Y Average)-65.35%
    ROIC (5Y Average)-98.16%
    Asset Turnover0.57x
    Receivables Turnover25.69x

    Scores

    GOSS has an Altman Z-Score of -40.49, in the distress zone below 1.81, and a Piotroski F-Score of 0 of 9, in the weak band of 0 to 2.

    Altman Z-Score-40.49
    Altman Z ZoneDistress
    Piotroski F-Score0 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $78.42M over the last 12 months.

    Revenue$78.42M
    Revenue Growth (YoY)+78.03%
    Gross Profit$78.42M
    Operating Income-$109.78M
    Pretax Income-$125.16M
    Net Income-$125.07M
    Reported EPS (TTM)-$1.80

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$51.19M
    Total Debt$37.15M
    Net Cash$14.04M
    Net Cash Per Share$2.15
    Working Capital-$39.52M
    Shareholder Equity-$122.80M
    Total Assets$64.34M
    Total Liabilities$187.13M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$156.04M
    FCF Per Share-$25.51
    Depreciation and Amortization$6.83M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -139.99%.

    Gross Margin100.00%
    Operating Margin-139.99%
    Pretax Margin-159.60%
    Net Margin-159.49%

    Dividends and Yields

    GOSS does not pay a dividend.

    Buyback Yield-33.30%
    Shareholder Yield-33.30%

    Stock Splits

    The last split was a 1-for-80 reverse split on Sep 11, 2026.

    Last Split DateSep 11, 2026
    Split TypeReverse split
    Split Ratio1:80

    Peer Position

    Against 7 similar companies, GOSS has the lowest P/S.

    P/S Ratio0.9x vs 40.1x median
    Revenue Growth (Trailing 4 Quarters, YoY)+78.03% vs +1.27% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -37.79% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-37.79%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About GOSS

    What is GOSS's market cap?

    Gossamer Bio has a market cap of $67.16M. Its enterprise value, which adds debt and subtracts cash, is $53.12M.

    How many shares of GOSS are outstanding?

    Gossamer Bio has 6.53M shares outstanding.

    Does GOSS pay a dividend?

    No. Gossamer Bio does not pay a dividend.

    How much debt does GOSS have?

    Gossamer Bio has $37.15M of total debt and $51.19M of cash and equivalents, a net cash position of $14.04M.